Summary of selected commercialisation metrics for Australia, Canada, Israel, US and UK 2004-2015

Sources: Australia, National Survey of Research Commercialisation (NSRC); AUTM US and Canadian Licensing Activity Surveys; AUTM Statistics Access for Tech Transfer (STATT) Database; UK Higher Education - Business Community Interaction Survey, and Israel Survey of Commercialization Companies, various years, Israel' Central Bureau Statistics

Notes:

  • UK ceased to collect data commercialisation staff (FTE) after 2012/13.
  • Israel does not collect data on the number of US patents issued
  • Patent data for Australia was missing starting in 2014 as they are now collected through IP Australia's Analytics Hub. Report on Australian patent data will be reported separately.
  • The figures in this table may differ from previous NSRC reports due to the use of the latest US$ Purchasing Power Parity (PPP) and the some of the data have been revised.
  • (-) data not available
  • For futher information, see the methodology on international data comparisions in the 2015 NSRC Methodology for full details.

Table 3a: Resourcing for Commercialisation (FTE)(No.)

 

2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015
Australia 7.9 8.0 7.9 7.9 11.2 11.6 11.2 11.2 10.3 12.5 9.8 9.8
Canada 8.3 7.8 7.9 9.1 9.9 9.5 8.9 9.1 9.5 8.8 8.0 8.3
Israel           4.3   5.8 5.2 5.3 4.6  
United Kingdom 14.1 17.1 21.6 24.0 25.0 25.1 25.7 26.5 27.5      
United States 8.3 8.9 9.6 9.9 11.0 11.6 11.8 11.7 11.8 11.6 12.3 12.5
 

Table 3b: Intellectual Property Activity - Invention Disclosures per USD100m Research Expenditure

  2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015
Australia 26.6 23.4 25.4 25.1 26.8 26.6 27.8 28.6 23.5 20.8 17.5 18.6
Canada 39.6 41.1 39.2 43.7 40.7 39.5 34.7 38.9 39.3 42.6 42.1 37.3
Israel         5.2 6.3 6.8 6.4 6.9 6.2 7.0 7.7
United Kingdom 53.5 59.0 57.9 52.9 45.1 44.3 46.5 47.1 45.0 43.2 39.3  
United States 40.8 41.1 41.6 40.6 38.7 37.6 35.0 35.8 37.3 36.9 38.3 38.0
 

Table 3c: Patents Issued Per US$100m Research Expenditure

  2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015
Australia 5.3 2.3 2.6 1.6 1.4 1.5 1.9 1.9 1.9 1.8    
Canada 4.5 4.1 3.1 3.9 2.7 2.5 2.9 3.9 4.0 5.2 6.0 5.6
United Kingdom 12.6 9.9 10.0 8.6 7.7 9.4 8.3 9.1 10.0 9.6 8.4  
United States 8.9 7.7 7.2 7.4 6.3 6.3 7.6 7.7 8.1 8.8 10.1 10.0
 

Table 3d: Licensing Activity- LOAs Executed per USD100m Research Expenditure (No.)

  2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015
Australia 10.6 11.5 12.1 11.4 9.4 9.0 8.7 8.4 8.3 9.3 10.6 8.8
Canada 16.5 16.4 11.9 16.0 14.1 14.2 10.8 12.3 12.0 11.0 12.6 14.4
Israel - - - - - - - 1.8 - 1.4 1.3 1.2
United Kingdom 37.1 46.2 50.8 46.7 52.7 54.4 56.0 78.7 94.8 145.6 364.1 -
United States 11.6 11.7 10.9 10.5 9.9 9.9 9.1 9.9 10.0 10.1 11.0 11.9
 

Table 3e: Ratio of LOA Income to Total Research Expenditure (%)

  2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015
Australia 1.3 1.4 2.1 3.3 1.5 3.9 1.9 1.6 3.9 1.3 1.4 1.8
Canada 1.4 1.2 1.4 1.2 1.0 1.0 1.0 1.1 1.3 1.0 1.6 1.0
Israel         4.7 5.4 4.8 4.5 4.6 4.0 3.6 -
United Kingdom 1.5 1.4 1.3 1.4 2.1 1.3 1.1 1.2 1.3 1.9 2.0 -
United States 3.6 5.0 4.8 4.9 6.6 4.3 4.1 4.0 4.1 4.2 4.3 3.8
 

Table 3f: Start-up Company Activity - Start-up Companies Formed per USD 100m Resesarch Expenditure (No.)

  2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015
Australia 0.9 1.0 1.0 0.8 0.3 0.5 0.3 0.3 0.4 0.4 0.1 0.6
Canada 1.4 1.0 0.8 1.1 0.9 1.0 1.0 1.5 1.3 1.5 1.8 1.9
Israel - - - - - - - 0.2 0.4 0.3 0.3 0.4
United Kingdom 2.6 3.2 3.5 3.2 2.3 2.8 3.0 2.1 1.6 1.4 1.2 -
United States 1.1 1.2 1.2 1.1 1.1 1.1 1.1 1.1 1.1 1.3 1.5 1.5